Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors

Cancer Cell

Volumn 32, Issue 1, 2017, Pages 27-41.e4

  Qu, Kun ^a,b   Zaba, Lisa C ^b   Satpathy, Ansuman T ^b   Giresi, Paul G ^c   Li, Rui ^b   Jin, Yonghao ^a   Armstrong, Randall ^b   Jin, Chen ^a   Schmitt, Nathalie ^d   Rahbar, Ziba ^b   Ueno, Hideki ^e   Greenleaf, William J ^b   Kim, Youn H ^b   Chang, Howard Y ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Epinomics   (United States)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cancer epigenetics; CTCL; HDAC inhibitor; response predictor

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; ROMIDEPSIN; TRANSCRIPTION FACTOR; VORINOSTAT; CHROMATIN; MESSENGER RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN; CHROMATIN STRUCTURE; COPY NUMBER VARIATION; CORRELATION ANALYSIS; CUTANEOUS T CELL LYMPHOMA; CYTOMETRY; EPIGENETICS; GENOMICS; HUMAN; MOLECULAR DYNAMICS; PRIORITY JOURNAL; TREATMENT RESPONSE; CHEMISTRY; CLUSTER ANALYSIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA, T-CELL, CUTANEOUS; METABOLISM;

CHROMATIN; CLUSTER ANALYSIS; EPIGENOMICS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; RNA, MESSENGER;

EID: 85020742421     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2017.05.008     Document Type: Article

References (62)

1. Adey, A., Morrison, H.G., Asan, Xun, X., Kitzman, J.O., Turner, E.H., Stackhouse, B., MacKenzie, A.P., Caruccio, N.C., Zhang, X., et al. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol., 11, 2010, R119.
2. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., Greenleaf, W.J., Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10 (2013), 1213–1218.
3. Buenrostro, J.D., Wu, B., Litzenburger, U.M., Ruff, D., Gonzales, M.L., Snyder, M.P., Chang, H.Y., Greenleaf, W.J., Single-cell chromatin accessibility reveals principles of regulatory variation. Nature 523 (2015), 486–490.
4. Chiappinelli, K.B., Strissel, P.L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N.S., Cope, L.M., Snyder, A., et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162 (2015), 974–986.
5. Choi, J., Goh, G., Walradt, T., Hong, B.S., Bunick, C.G., Chen, K., Bjornson, R.D., Maman, Y., Wang, T., Tordoff, J., et al. Genomic landscape of cutaneous T cell lymphoma. Nat. Genet. 47 (2015), 1011–1019.
6. Corces-Zimmerman, M.R., Hong, W.J., Weissman, I.L., Medeiros, B.C., Majeti, R., Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl. Acad. Sci. USA 111 (2014), 2548–2553.
7. Corces, M.R., Buenrostro, J.D., Wu, B., Greenside, P.G., Chan, S.M., Koenig, J.L., Snyder, M.P., Pritchard, J.K., Kundaje, A., Greenleaf, W.J., et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48 (2016), 1193–1203.
8. Cusanovich, D.A., Daza, R., Adey, A., Pliner, H.A., Christiansen, L., Gunderson, K.L., Steemers, F.J., Trapnell, C., Shendure, J., Epigenetics. Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing. Science 348 (2015), 910–914.
9. da Silva Almeida, A.C., Abate, F., Khiabanian, H., Martinez-Escala, E., Guitart, J., Tensen, C.P., Vermeer, M.H., Rabadan, R., Ferrando, A., Palomero, T., The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome. Nat. Genet. 47 (2015), 1465–1470.
10. de Hoon, M.J., Imoto, S., Nolan, J., Miyano, S., Open source clustering software. Bioinformatics 20 (2004), 1453–1454.
11. Denny, S.K., Yang, D., Chuang, C.H., Brady, J.J., Lim, J.S., Gruner, B.M., Chiou, S.H., Schep, A.N., Baral, J., Hamard, C., et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166 (2016), 328–342.
12. Dolnik, A., Engelmann, J.C., Scharfenberger-Schmeer, M., Mauch, J., Kelkenberg-Schade, S., Haldemann, B., Fries, T., Kronke, J., Kuhn, M.W., Paschka, P., et al. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing. Blood 120 (2012), e83–92.
13. Dulmage, B.O., Geskin, L.J., Lessons learned from gene expression profiling of cutaneous T-cell lymphoma. Br. J. Dermatol. 169 (2013), 1188–1197.
14. Dummer, R., Heald, P.W., Nestle, F.O., Ludwig, E., Laine, E., Hemmi, S., Burg, G., Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 88 (1996), 1383–1389.
15. Ernst, J., Kellis, M., ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9 (2012), 215–216.
16. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W.B., Fedorov, O., Morse, E.M., Keates, T., Hickman, T.T., Felletar, I., et al. Selective inhibition of BET bromodomains. Nature 468 (2010), 1067–1073.
17. Flavahan, W.A., Drier, Y., Liau, B.B., Gillespie, S.M., Venteicher, A.S., Stemmer-Rachamimov, A.O., Suva, M.L., Bernstein, B.E., Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529 (2016), 110–114.
18. Fontenot, J.D., Gavin, M.A., Rudensky, A.Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003), 330–336.
19. Fontenot, J.D., Rasmussen, J.P., Williams, L.M., Dooley, J.L., Farr, A.G., Rudensky, A.Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005), 329–341.
20. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., Glass, C.K., Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38 (2010), 576–589.
21. Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003), 1057–1061.
22. Jan, M., Snyder, T.M., Corces-Zimmerman, M.R., Vyas, P., Weissman, I.L., Quake, S.R., Majeti, R., Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci. Transl. Med., 4, 2012, 149ra118.
23. Jawed, S.I., Myskowski, P.L., Horwitz, S., Moskowitz, A., Querfeld, C., Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. J. Am. Acad. Dermatol., 70, 2014, 223.e1-17 quiz 240–2.
24. Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564.
25. Landt, S.G., Marinov, G.K., Kundaje, A., Kheradpour, P., Pauli, F., Batzoglou, S., Bernstein, B.E., Bickel, P., Brown, J.B., Cayting, P., et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 22 (2012), 1813–1831.
26. Langmead, B., Salzberg, S.L., Fast gapped-read alignment with Bowtie 2. Nat. Methods 9 (2012), 357–359.
27. Lara-Astiaso, D., Weiner, A., Lorenzo-Vivas, E., Zaretsky, I., Jaitin, D.A., David, E., Keren-Shaul, H., Mildner, A., Winter, D., Jung, S., et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 345 (2014), 943–949.
28. Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., Amit, I., Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159 (2014), 1312–1326.
29. Lee, C.S., Ungewickell, A., Bhaduri, A., Qu, K., Webster, D.E., Armstrong, R., Weng, W.K., Aros, C.J., Mah, A., Chen, R.O., et al. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Blood 120 (2012), 3288–3297.
30. Limbach, M., Saare, M., Tserel, L., Kisand, K., Eglit, T., Sauer, S., Axelsson, T., Syvanen, A.C., Metspalu, A., Milani, L., et al. Epigenetic profiling in CD4+ and CD8+ T cells from Graves’ disease patients reveals changes in genes associated with T cell receptor signaling. J. Autoimmun. 67 (2016), 46–56.
31. Mathelier, A., Fornes, O., Arenillas, D.J., Chen, C.Y., Denay, G., Lee, J., Shi, W., Shyr, C., Tan, G., Worsley-Hunt, R., et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 44 (2016), D110–D115.
32. Mazumdar, C., Shen, Y., Xavy, S., Zhao, F., Reinisch, A., Li, R., Corces, M.R., Flynn, R.A., Buenrostro, J.D., Chan, S.M., et al. Leukemia-associated cohesin mutants dominantly enforce stem cell programs and impair human hematopoietic progenitor differentiation. Cell Stem Cell 17 (2015), 675–688.
33. McLean, C.Y., Bristor, D., Hiller, M., Clarke, S.L., Schaar, B.T., Lowe, C.B., Wenger, A.M., Bejerano, G., GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28 (2010), 495–501.
34. Morita, R., Schmitt, N., Bentebibel, S.E., Ranganathan, R., Bourdery, L., Zurawski, G., Foucat, E., Dullaers, M., Oh, S., Sabzghabaei, N., et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34 (2011), 108–121.
35. New, M., Olzscha, H., La Thangue, N.B., HDAC inhibitor-based therapies: can we interpret the code?. Mol. Oncol. 6 (2012), 637–656.
36. Newman, A.M., Liu, C.L., Green, M.R., Gentles, A.J., Feng, W., Xu, Y., Hoang, C.D., Diehn, M., Alizadeh, A.A., Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12 (2015), 453–457.
37. Niess, H., Camaj, P., Mair, R., Renner, A., Zhao, Y., Jackel, C., Nelson, P.J., Jauch, K.W., Bruns, C.J., Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular “pseudoinflammation” contributing to an aggressive phenotype. Oncotarget 6 (2015), 3306–3318.
38. Olsen, E.A., Whittaker, S., Kim, Y.H., Duvic, M., Prince, H.M., Lessin, S.R., Wood, G.S., Willemze, R., Demierre, M.F., Pimpinelli, N., et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J. Clin. Oncol. 29 (2011), 2598–2607.
39. Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature 527 (2015), 249–253.
40. Phillips, J.E., Corces, V.G., CTCF: master weaver of the genome. Cell 137 (2009), 1194–1211.
41. Platanias, L.C., Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5 (2005), 375–386.
42. Qu, K., Zaba, L.C., Giresi, P.G., Li, R., Longmire, M., Kim, Y.H., Greenleaf, W.J., Chang, H.Y., Individuality and variation of personal regulomes in primary human T cells. Cell Syst. 1 (2015), 51–61.
43. Quinlan, A.R., Hall, I.M., BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26 (2010), 841–842.
44. Quinn, E.M., Coleman, C., Molloy, B., Dominguez Castro, P., Cormican, P., Trimble, V., Mahmud, N., McManus, R., Transcriptome analysis of CD4+ T cells in coeliac disease reveals imprint of BACH2 and IFNgamma regulation. PLoS One, 10, 2015, e0140049.
45. Roadmap Epigenomics, C., Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. Integrative analysis of 111 reference human epigenomes. Nature 518 (2015), 317–330.
46. Rodriguez-Paredes, M., Esteller, M., Cancer epigenetics reaches mainstream oncology. Nat. Med. 17 (2011), 330–339.
47. Segal, E., Friedman, N., Koller, D., Regev, A., A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36 (2004), 1090–1098.
48. Sharrocks, A.D., The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2 (2001), 827–837.
49. Sherwood, R.I., Hashimoto, T., O'Donnell, C.W., Lewis, S., Barkal, A.A., van Hoff, J.P., Karun, V., Jaakkola, T., Gifford, D.K., Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape. Nat. Biotechnol. 32 (2014), 171–178.
50. Simon Anders, W.H., Differential expression analysis for sequence count data. Genome Biol., 11, 2010, R106.
51. Tao, R., de Zoeten, E.F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P.M., Li, B., Turka, L.A., Olson, E.N., Greene, M.I., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13 (2007), 1299–1307.
52. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L., Pachter, L., Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7 (2012), 562–578.
53. Ungewickell, A., Bhaduri, A., Rios, E., Reuter, J., Lee, C.S., Mah, A., Zehnder, A., Ohgami, R., Kulkarni, S., Armstrong, R., et al. Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2. Nat. Genet. 47 (2015), 1056–1060.
54. Willemze, R., Jaffe, E.S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S.H., Ralfkiaer, E., Chimenti, S., Diaz-Perez, J.L., Duncan, L.M., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005), 3768–3785.
55. Woollard, W.J., Pullabhatla, V., Lorenc, A., Patel, V.M., Butler, R.M., Bayega, A., Begum, N., Bakr, F., Dedhia, K., Fisher, J., et al. Candidate driver genes involved in genome maintenance and DNA repair in Sezary syndrome. Blood 127 (2016), 3387–3397.
56. Wu, J., Wood, G.S., Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma. Arch. Dermatol. 147 (2011), 443–449.
57. Xu, C.Z., Shi, R.J., Chen, D., Sun, Y.Y., Wu, Q.W., Wang, T., Wang, P.H., Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. Int. J. Clin. Exp. Pathol. 6 (2013), 2745–2756.
58. Yoshida, K., Toki, T., Okuno, Y., Kanezaki, R., Shiraishi, Y., Sato-Otsubo, A., Sanada, M., Park, M.J., Terui, K., Suzuki, H., et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat. Genet. 45 (2013), 1293–1299.
59. Yu, H., Pardoll, D., Jove, R., STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9 (2009), 798–809.
60. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., et al. Model-based analysis of ChIP-seq (MACS). Genome Biol., 9, 2008, R137.
61. Zhang, T., Inesta-Vaquera, F., Niepel, M., Zhang, J., Ficarro, S.B., Machleidt, T., Xie, T., Marto, J.A., Kim, N., Sim, T., et al. Discovery of potent and selective covalent inhibitors of JNK. Chem. Biol. 19 (2012), 140–154.
62. Zhao, M., Sun, J., Zhao, Z., TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res. 41 (2013), D970–D976.